Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression
Hikmat Permana, Theo Audi Yanto, Timotius Ivan Hariyanto
Topics & Concepts
MedicineMeta-analysisDiabetes mellitusOdds ratioInternal medicineConfidence intervalCochrane LibraryMetforminCoronavirus disease 2019 (COVID-19)Hazard ratioMEDLINEEndocrinologyDiseasePolitical scienceInfectious disease (medical specialty)LawDiabetes Treatment and ManagementCOVID-19 Clinical Research StudiesHyperglycemia and glycemic control in critically ill and hospitalized patients